We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toFuture-of-PharmaTech

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Future of PharmaTech

    Session Chair(s)
      Patrick K Brady, PharmD

      Patrick K Brady, PharmD

      • Regulatory Policy and Intelligence
      • Bayer, United States
    What is PharmaTech? How is the pharmaceutical and biotech industry evolving with new technologies, such as artifical intelligence (AI) and block chain? How will the business model be impacted? Are there lessons learned from other industries?

    This DIAmond session will examine how innovative technologies in drug development are impacting the pharmaceutical and biotech industry.
    Learning Objective : Define the concept of PharmaTech and describe it's impact on new technologies and business models; Identify how the pharmaceutical and biotech industry will be impacted by innovative technologies, such as artificial intelligence, in drug development.
      Dave  Meyers


      Dave Meyers

      • National Director, Life Sciences
      • Microsoft, United States
      Dina  Katabi, PhD, MS


      Dina Katabi, PhD, MS

      • Professor
      • MIT, United States
      Sudip  Parikh, PhD


      Sudip Parikh, PhD

      • Senior Vice President and Managing Director, DIA Americas
      • DIA, United States
      Henry "Skip" Francis


      Henry "Skip" Francis

      • Director for Data Mining and Informatics Evaluation and Research, OTS, CDER
      • FDA, United States